174 related articles for article (PubMed ID: 25099026)
1. Mesoporous silica supraparticles for sustained inner-ear drug delivery.
Wang Y; Wise AK; Tan J; Maina JW; Shepherd RK; Caruso F
Small; 2014 Nov; 10(21):4244-8. PubMed ID: 25099026
[TBL] [Abstract][Full Text] [Related]
2. Improved Auditory Nerve Survival with Nanoengineered Supraparticles for Neurotrophin Delivery into the Deafened Cochlea.
Wise AK; Tan J; Wang Y; Caruso F; Shepherd RK
PLoS One; 2016; 11(10):e0164867. PubMed ID: 27788219
[TBL] [Abstract][Full Text] [Related]
3. Mold-templated inorganic-organic hybrid supraparticles for codelivery of drugs.
Maina JW; Cui J; Björnmalm M; Wise AK; Shepherd RK; Caruso F
Biomacromolecules; 2014 Nov; 15(11):4146-51. PubMed ID: 25321318
[TBL] [Abstract][Full Text] [Related]
4. Mesoporous silica nanoparticles for intracellular controlled drug delivery.
Vivero-Escoto JL; Slowing II; Trewyn BG; Lin VS
Small; 2010 Sep; 6(18):1952-67. PubMed ID: 20690133
[TBL] [Abstract][Full Text] [Related]
5. Nanoporous peptide particles for encapsulating and releasing neurotrophic factors in an animal model of neurodegeneration.
Tan J; Wang Y; Yip X; Glynn F; Shepherd RK; Caruso F
Adv Mater; 2012 Jul; 24(25):3362-6. PubMed ID: 22610659
[TBL] [Abstract][Full Text] [Related]
6. Development of a drug delivery system for the inner ear using poly(amino acid)-based nanoparticles.
Kim DK; Park SN; Park KH; Park CW; Yang KJ; Kim JD; Kim MS
Drug Deliv; 2015 May; 22(3):367-74. PubMed ID: 24447111
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and biodistribution of supraparticle-delivered neurotrophin 3 in the guinea pig cochlea.
Gunewardene N; Lam P; Ma Y; Caruso F; Wagstaff S; Richardson RT; Wise AK
J Control Release; 2022 Feb; 342():295-307. PubMed ID: 34999140
[TBL] [Abstract][Full Text] [Related]
8. Gel-Mediated Electrospray Assembly of Silica Supraparticles for Sustained Drug Delivery.
Ma Y; Björnmalm M; Wise AK; Cortez-Jugo C; Revalor E; Ju Y; Feeney OM; Richardson RT; Hanssen E; Shepherd RK; Porter CJH; Caruso F
ACS Appl Mater Interfaces; 2018 Sep; 10(37):31019-31031. PubMed ID: 30192499
[TBL] [Abstract][Full Text] [Related]
9. Preparation of a push-pull osmotic pump of felodipine solubilized by mesoporous silica nanoparticles with a core-shell structure.
Wu C; Zhao Z; Zhao Y; Hao Y; Liu Y; Liu C
Int J Pharm; 2014 Nov; 475(1-2):298-305. PubMed ID: 25148731
[TBL] [Abstract][Full Text] [Related]
10. Capped mesoporous silica nanoparticles as stimuli-responsive controlled release systems for intracellular drug/gene delivery.
Zhao Y; Vivero-Escoto JL; Slowing II; Trewyn BG; Lin VS
Expert Opin Drug Deliv; 2010 Sep; 7(9):1013-29. PubMed ID: 20716017
[TBL] [Abstract][Full Text] [Related]
11. Mesoporous inorganic nanoscale particles for drug adsorption and controlled release.
Cavallaro G; Lazzara G; Fakhrullin R
Ther Deliv; 2018 Mar; 9(4):287-301. PubMed ID: 29495930
[TBL] [Abstract][Full Text] [Related]
12. Developing the supraparticle technology for round window-mediated drug administration into the cochlea.
Gunewardene N; Ma Y; Lam P; Wagstaff S; Cortez-Jugo C; Hu Y; Caruso F; Richardson RT; Wise AK
J Control Release; 2023 Sep; 361():621-635. PubMed ID: 37572963
[TBL] [Abstract][Full Text] [Related]
13. Novel strategy for treatment of inner ears using a biodegradable gel.
Endo T; Nakagawa T; Kita T; Iguchi F; Kim TS; Tamura T; Iwai K; Tabata Y; Ito J
Laryngoscope; 2005 Nov; 115(11):2016-20. PubMed ID: 16319616
[TBL] [Abstract][Full Text] [Related]
14. Intracellular degradation of multilabeled poly(ethylene imine)-mesoporous silica-silica nanoparticles: implications for drug release.
Bergman L; Kankaanpää P; Tiitta S; Duchanoy A; Li L; Heino J; Lindén M
Mol Pharm; 2013 May; 10(5):1795-803. PubMed ID: 23510188
[TBL] [Abstract][Full Text] [Related]
15. Drug delivery from ordered mesoporous matrices.
Manzano M; Colilla M; Vallet-Regí M
Expert Opin Drug Deliv; 2009 Dec; 6(12):1383-400. PubMed ID: 19941412
[TBL] [Abstract][Full Text] [Related]
16. Dose-dependent sustained release of dexamethasone in inner ear cochlear fluids using a novel local delivery approach.
Wang X; Dellamary L; Fernandez R; Harrop A; Keithley EM; Harris JP; Ye Q; Lichter J; LeBel C; Piu F
Audiol Neurootol; 2009; 14(6):393-401. PubMed ID: 19923809
[TBL] [Abstract][Full Text] [Related]
17. Inner ear therapy for neural preservation.
Richardson RT; Noushi F; O'Leary S
Audiol Neurootol; 2006; 11(6):343-56. PubMed ID: 16988498
[TBL] [Abstract][Full Text] [Related]
18. The viability of mesoporous silica nanoparticles for drug delivery.
Zhang J; Rosenholm JM
Ther Deliv; 2015; 6(8):891-3. PubMed ID: 26271998
[No Abstract] [Full Text] [Related]
19. Silica materials in drug delivery applications.
Simovic S; Ghouchi-Eskandar N; Sinn AM; Losic D; Prestidge CA
Curr Drug Discov Technol; 2011 Sep; 8(3):269-76. PubMed ID: 21291408
[TBL] [Abstract][Full Text] [Related]
20. Development of insulin loaded mesoporous silica injectable particles layered by chitosan as a controlled release delivery system.
Elsayed A; Al-Remawi M; Maghrabi I; Hamaidi M; Jaber N
Int J Pharm; 2014 Jan; 461(1-2):448-58. PubMed ID: 24368103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
